Third Rock Ventures

Venture capital · Boston, MA

Third Rock Ventures is a venture capital firm based in Boston, MA. 12 portfolio companies and 6 funds are on record.

AUM
—
Portfolio companies
12
Recorded deals
—
Last investment
—

Third Rock Ventures key facts

  • Third Rock Ventures is a venture capital firm based in Boston, MA with 12 tracked portfolio companies.
  • Notable positions include Seaport Therapeutics, Candid Therapeutics, Marea.
  • Third Rock Ventures has 6 funds on record, raising $4.1B across the 6 that report a size.

Third Rock Ventures portfolio at a glance

12 portfolio companies are on record for Third Rock Ventures, including Seaport Therapeutics, Candid Therapeutics and Marea.

8 of the 12 carry a recorded valuation.

Third Rock Ventures funds

6 funds are on record for Third Rock Ventures, totalling $4.1 billion across the 6 that report a size. The most recent is Third Rock Ventures VII, L.P. (2026 vintage), $750 million.

Is this your firm? Sign in with your work email to keep it current, or tell us what's wrong.

Free account
See more of the book
  • ·The top 10 names in the book — of 12 recorded positions
  • ·Watchlist + alerts for Third Rock Ventures's activity
Create free account

Membership and data by Private Market View

No card required

Portfolio

12 companies · priced for members
CompanyValuationRole
Seaport Therapeutics▮▮
Candid Therapeutics▮▮
Marea▮▮
+ 9 more companies · all 12, priced and dated
or a free account shows the top 10 names — no card
The whole book · Pro $99 a month

Membership and data by Private Market View

Funds

6 recorded
  • Third Rock Ventures VII, L.P.2026$750.0M
  • Third Rock Ventures VI, L.P.2022$1.1B
  • Third Rock Ventures V, L.P.2019$750.0M
  • Third Rock Ventures IV, L.P.2016$600.0M
  • Third Rock Ventures III, L.P.2013$500.0M
  • Third Rock Ventures II, L.P.2010$400.0M

$4.1B raised across the 6 funds that report a size

Frequently asked about Third Rock Ventures

What companies does Third Rock Ventures invest in?
Third Rock Ventures has 12 recorded portfolio companies, including Seaport Therapeutics, Candid Therapeutics, Marea.